The decision is a big win for medical marijuana advocates, many whom have long said cannabis is effective in treating PTSD.
In announcing his decision, Humble cited a recent study published in the Journal of Psychoactive Drugs that provides evidence that marijuana may be helpful in the palliative care of PTSD in some patients.
“Today I issued a Director’s Decision that will authorize the use of marijuana … for patients that are currently undergoing conventional treatment for a diagnosis of PTSD,” Humble wrote in a blog post to be published Wednesday on the health department’s website. “Physician certifications would be valid only for the palliative care of PTSD symptoms (not treatment). Certifying physicians will be required to attest that they have reviewed evidence documenting that the patient is currently undergoing conventional treatment for PTSD before signing the medical marijuana certification.”
The new policy won’t take effect until Jan. 1 in order to give health officials and dispensaries time to develop policies and procedures and educational materials, as required by the rules.